Jordana Joy, Associate Editor

Additionally, the company is exploring different strategic alternative to advance its suprachoroidal space (SCS) platform and drug development pipeline.

The solution was approved by the US Food and Drug Administration in late May 2025.

The new facility has opened just in time to see its first classes held in the fall semester.

The expanded clinical suite at Stanton Optical will include keratography, optical coherence tomography, and personalized therapy options for patients with dry eye.

The first-in-class, twice-daily topical formulation is intended for the treatment of nonproliferative diabetic retinopathy and diabetic macular edema.

A total of $7000 in scholarships was awarded to 3 optometry students as part of the National Optometric Student Association (NOSA) scholarship program.

The study's primary objective was to demonstrate that LUMIFY Preservative Free redness reliever eye drops are noninferior to LUMIFY redness reliever eye drops in reducing ocular redness.

The module can be used in combination with Ziemer’s FEMTO LDV Z8 femtosecond laser platform, an all-in-one laser for refractive, cataract, and therapeutic surgery.

The company was presented with the PRMA President’s Award, Platinum Recycling Award, and recognitions in Leadership in Environmental Performance.

Catch up on the top stories in optometry during the week of July 21-July 25.

The enhanced clarity in the lens helps reduce glare and enhance visual comfort, according to the company.

The campaign provides tools to patients, researchers, clinicians, industry, and advocates with tools to tell their stories that advocate for vision research.

The tool is designed to help with the application of mono-dose, dry eye eye drop vials more easily and accurately.

The EyeSouth affiliate network now includes more than 320 doctors providing medical and surgical eye care services at over 235 locations.

This will be the Flying Eye Hospital’s first visit to Rwanda.

Survey participants cited cost concerns, perceived inevitability, and deprioritization as obstacles to receiving eye care.

The bill will make 3 changes that enhance oral medication usage, with 1 change expanding access to in-office procedures.

Catch up on the top stories in optometry during the week of July 14-July 18.

Nicox’s nitric oxide (NO)-donating bimatoprost eye drop works to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.

Study authors Preeya K. Gupta, MD; and Paul Karpecki, OD, formulated a case in their literature review for the routine evaluation of the upper eyelid during meibomian gland imaging.

ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.

These screening solutions will work to make early detection of diabetic retinopathy easier with on-the-spot screening.

The Topical Sustain Release drop technology was designed to address suboptimal patient adherence and high treatment cost.

Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.

Nora Lee Cothran, OD, FAAO, moderated an Innovation Hub panel that featured 3 companies, giving insights into what's to come in the optometric industry.

Joe Shovlin, OD, FAAO, sat down with Optometry Times to detail a presentation he gave at AOA's Optometry's Meeting 2025.

From blue light blockers to sleep apnea, Jacqueline Theis, OD, FAAO, FNAP; and Joseph Allen, OD, FAAO, Dipl ABO, outlined how sleep can influence brain and ocular health, and vice versa.

The DSLT technology has been fully commercially available in the US since February 2025.

Catch up on the top stories in optometry during the week of July 7-July 11.

Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.